Although progress is being made against breast cancer in general, it seems African American women are being left behind.
The study entitled Distinct and targetable molecular features of breast cancer in African American women” was aimed at determining if breast cancer occurring in African American women might have different molecular features.
Read MoreProtean BioDiagnostics presents a new method to identify potential therapeutic targets in breast cancer.
The method called OncoSignal analysis utilizes mRNA transcriptional measurements to accurately calculate the pathway activity of seven key oncogenic signaling pathways.
Read MoreProtean BioDiagnostics is thrilled to be recognized by Orange County Mayor, Jerry L. Demings in his annual state of the County address on Jun 4th, 2021 at the Orlando convention center.
Read MoreProtean is pleased to announce that its below-referenced abstract has been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Virtual Annual Meeting.
Read MoreBreast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreBreast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read More
